CRIS Current Research Information System

VUKOTIC, RANKA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.230
EU - Europa 1.362
AS - Asia 766
AF - Africa 118
SA - Sud America 5
OC - Oceania 2
Totale 4.483
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.224
GB - Regno Unito 348
SE - Svezia 257
VN - Vietnam 243
CN - Cina 226
IT - Italia 218
DE - Germania 187
SG - Singapore 173
IE - Irlanda 76
IN - India 76
RU - Federazione Russa 51
FR - Francia 48
TG - Togo 47
UA - Ucraina 42
JO - Giordania 28
ZA - Sudafrica 27
EE - Estonia 25
BE - Belgio 22
NG - Nigeria 21
BG - Bulgaria 20
CI - Costa d'Avorio 18
GR - Grecia 15
NL - Olanda 12
CH - Svizzera 11
FI - Finlandia 7
CA - Canada 6
HR - Croazia 5
ID - Indonesia 5
ES - Italia 4
PL - Polonia 4
SC - Seychelles 4
HK - Hong Kong 3
JP - Giappone 3
BR - Brasile 2
CL - Cile 2
CZ - Repubblica Ceca 2
IR - Iran 2
KR - Corea 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
IL - Israele 1
LB - Libano 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 4.483
Salva come PNG Salva come JPEG
Città #
Southend 318
Fairfield 279
Chandler 245
Dong Ket 214
Ashburn 165
Singapore 154
Woodbridge 134
Seattle 131
Wilmington 121
Houston 117
Ann Arbor 114
Santa Clara 106
Cambridge 95
Princeton 78
Dublin 76
Boardman 52
Lomé 47
Westminster 36
Bologna 35
Nanjing 34
Amman 28
Berlin 26
Padova 25
Florence 23
Brussels 22
Abeokuta 21
Sofia 20
Jacksonville 19
Abidjan 18
Bremen 18
Turin 18
New York 17
Beijing 15
Saint Petersburg 15
San Diego 13
Guangzhou 12
Jinan 12
Los Angeles 11
Redmond 11
Medford 9
Shenyang 9
Bern 8
Des Moines 8
Nanchang 8
Falls Church 7
Milan 7
Buffalo 6
Helsinki 6
Jiaxing 6
Rome 6
Zola Predosa 6
Bühl 5
Changsha 5
Dearborn 5
Jakarta 5
Ningbo 5
Norwalk 5
Redwood City 5
Shanghai 5
Wuhan 5
Chengdu 4
Costa Mesa 4
Faenza 4
Hebei 4
Lanzhou 4
Lucca 4
Mahé 4
Moscow 4
Tianjin 4
Toronto 4
Athens 3
Chicago 3
Den Haag 3
Falkenstein 3
Fuzhou 3
Hangzhou 3
Hyderabad 3
Las Vegas 3
Mülheim 3
Paris 3
Pune 3
Tokyo 3
Washington 3
Yuncheng 3
Zhengzhou 3
Amsterdam 2
Bolgare 2
Cagliari 2
Casalecchio di Reno 2
Castenaso 2
Dongguan 2
Foshan 2
Frankfurt am Main 2
Grafing 2
Groningen 2
Harbin 2
Lausanne 2
Livorno 2
London 2
Munich 2
Totale 3.141
Salva come PNG Salva come JPEG
Nome #
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 221
Clinical and serological profile of primary biliary cirrhosis in men. 178
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 174
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 160
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 157
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C 156
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 155
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 152
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 140
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 138
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B. 127
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 127
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 127
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients. 124
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 122
Hepatitis B virus and immune response. 120
Non-invasive measurement of HVPG using graph analysis based on dynamic contrast-enhanced ultrasound with ESAOTE MyLab: The CLEVER Study. 119
Non-alcoholic steatohepatitis and liver transplantation 119
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 108
De novo autoimmune hepatitis in liver transplant: State-of-the-art review 107
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study. 103
Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods 103
null 103
null 96
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir? 94
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 94
Insights into cancer severity from biomolecular interaction mechanisms 93
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 92
Impact of psychosocial status on liver transplant process 87
Bone marrow derived stem cells for the treatment of end-stage liver disease. 86
LI-RADS: a great opportunity not to be missed 84
Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease 80
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing 79
Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy options 77
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 73
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C. 72
Psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects 61
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 59
Familial intrahepatic cholestasis: New and wide perspectives 59
Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group 58
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 54
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients 35
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib 30
Totale 4.603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020678 0 0 0 0 0 117 137 139 134 68 41 42
2020/2021632 107 39 26 22 18 21 12 36 53 28 24 246
2021/2022848 88 41 36 50 73 51 21 45 31 73 220 119
2022/20231.015 94 165 60 138 70 82 21 35 186 25 98 41
2023/2024256 19 47 33 21 23 52 10 12 6 18 6 9
2024/2025542 40 109 75 107 153 58 0 0 0 0 0 0
Totale 4.603